InvestorsHub Logo
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 1886

Friday, 10/30/2020 9:33:00 AM

Friday, October 30, 2020 9:33:00 AM

Post# of 2961
ABBV 3Q20 Mavyret sales=$414M, +10% QoQ, -41% YoY:

As reported by GILD yesterday (#msg-159176251), COVID-19 continued to impede new-HCV-patient starts during 3Q20.

The 3Q20 Mavyret breakdown was: $185M US; $214M ex-US.

2020 Mavyret sales for the first nine months are now $1.34B.

PR:
https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-third-quarter-2020-financial-results

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News